Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18] RGD-K5 PET in Carotid Artery Stenosis
NCT03364270Phase 2Completed
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of flotegatide in carotid artery stenosis (CAS). Primary endpoint: Uptake of [F-18] RGD-K5 by Carotid Plaque With PET/MRI Imaging. Started Oct 2018; status: completed.
02
Drugs
flotegatide
03
Conditions
carotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT03364270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364270.